People | January 23, 2023
SK bioscience appoints new executives
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
It is estimated that over 11,000 children across Europe, Middle East, and Africa are affected by achondroplasia and could be eligible for treatment with Voxzogo
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)